1-6 of 6
Jane Burgess
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Development of CAR T-cell lymphoma in 2 of 10 patients effectively treated with piggyBac -modified CD19 CAR T cells

Clinical Trials & Observations
David C. Bishop, Leighton E. Clancy, Renee Simms, Jane Burgess, Geetha Mathew, Leili Moezzi, Janine A. Street, Gaurav Sutrave, Elissa Atkins, Helen M. McGuire, Brian S. Gloss, Koon Lee, Wei Jiang, Karen Maddock, Georgia McCaughan, Selmir Avdic, Vicki Antonenas, Tracey A. O’Brien, Peter J. Shaw, David O. Irving, David J. Gottlieb, Emily Blyth, Kenneth P. Micklethwaite
Journal: Blood
Blood (2021) 138 (16): 1504–1509.
https://doi.org/10.1182/blood.2021010813
Published: 2021
Includes: Supplemental data
Journal Articles

3rd Party CMV-Specific T Cells Provide Long Term Protection Against Episodes of Recurrent CMV after Allogeneic Stem Cell Transplant Despite Lack of Persistence in Peripheral Blood

Emily Blyth, Barbara Withers, Leighton Edward Clancy, PhD, Agnes S. M. Yong, MDPhD, Christopher Fraser, MD, Jane Burgess, Renee Simms, Gloria Castellano Gonzalez, PhD, David Kliman, MBBS, Ming-Celine Dubosq, MD, David Bishop, Gaurav Sutrave, MBBS,, Chun Kei Kris Ma, PhDMBBS, Peter J. Shaw, MA,FRACP, Kenneth P. Micklethwaite, MBBS, PhD FRACP, FRCPA, David Gottlieb, MBBS, MD FRACP, FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 1919.
https://doi.org/10.1182/blood.V130.Suppl_1.1919.1919
Published: 2017
Journal Articles

Third-Party Donor Virus-Specific T Cells Are Efficacious in the Treatment of Refractory Viral Infection Following Allogeneic HSCT, but May Not Persist Post-Infusion

Barbara Withers, MBBS, Emily Blyth, MBBS, PhD, Leighton Clancy, PhD, Jane Burgess, Renee Simms, Kenneth Micklethwaite, MBBS, PhD, David Gottlieb, MBBS, MD
Journal: Blood
Blood (2015) 126 (23): 623.
https://doi.org/10.1182/blood.V126.23.623.623
Published: 2015
Journal Articles

Therapeutic Infusion of Partially HLA-Matched Third-Party Virus-Specific T Cells in HSCT Patients with Refractory Viral Infection

Leighton Edward Clancy, PhD, Emily Blyth, Barbara Withers, Jane Burgess, Renee Simms, Chun Kei Kris Ma, B.Sc (MD MB BS FRACP FRCPA, Kenneth P. Micklethwaite, MD PhD, David Gottlieb, MB MDFRCPA FRACP
Journal: Blood
Blood (2014) 124 (21): 3835.
https://doi.org/10.1182/blood.V124.21.3835.3835
Published: 2014
Journal Articles

Prophylactic Infusion Of Multi-Virus Specific T Cells For Management Of Viral Reactivation and Infection In Patients Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Chun Kei Kris Ma, B.Sc (Med) MB BS FRACP FRCPA, Emily Blyth, Leighton Clancy, Renee Simms, Jane Burgess, Kenneth P. Micklethwaite, MD, PhD, David Gottlieb, MB, PhD, FRCPA, FRACP
Journal: Blood
Blood (2013) 122 (21): 4498.
https://doi.org/10.1182/blood.V122.21.4498.4498
Published: 2013
Journal Articles

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

Emily Blyth, Leighton Clancy, Renee Simms, Chun K. K. Ma, Jane Burgess, Shivashni Deo, Karen Byth, Ming-Celine Dubosq, Peter J. Shaw, Kenneth P. Micklethwaite, David J. Gottlieb
Journal: Blood
Blood (2013) 121 (18): 3745–3758.
https://doi.org/10.1182/blood-2012-08-448977
Published: 2013